Scholarlink

Background <p>Amongst genetic causes of nephrotic syndrome (NS), mutations in the <i>PLCΕ1</i> gene have been described in patients with early onset NS and diffuse mesangial sclerosis (DMS). However, little is known about how these mutations alter podocyte biology although a role in podocyte differentiation has been proposed (Yu S, et al. Exp Mol Med. 52(4):594–603,2020).</p> Methods <p>To explore the role of PLCε in podocytes, A conditionally immortalised human podocyte cell line was generated from a patient with early onset NS, due to a nonsense <i>PLCΕ1</i> mutation, resulting histologically in diffuse mesangial sclerosis (DMS).</p> Results <p>In comparison to wild type podocytes, the <i>PLCΕ1</i> mutant podocyte cell has reduced epithelial features, altered actin cytoskeleton and significantly lower levels of the epithelial marker ZO-1.</p> Conclusions <p>We demonstrate that PLCε deficiency is associated with functionally impaired TGF-β1 responses with an altered SMAD2/SMAD3 ratio and absent SMAD2 phosphorylation, resulting in loss of the motility response to TGF-β1. We further show that <i>PLCE1</i> knockdown in wild-type podocytes recapitulates this phenotype by knock-down of <i>PLCΕ1</i> in wild-type podocytes.</p> <p>This work reveals that disease-causing mutations in <i>PLCΕ1</i> result in podocyte dedifferentiation and uncovers a novel association between <i>PLCΕ1</i> deficiency and SMAD2/3 signalling signalling in maintaining podocyte differentiation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

PLCε regulates podocyte differentiation and TGF-β1 responses via alteration of SMAD2/SMAD3 ratio

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月14日

查看全文
  • Carl J May,
  • Sarah E Hunter,
  • Agnieszka Bierzynska,
  • Lan Ni,
  • Katherine R Bull,
  • Aneesha Bhandari,
  • Gavin I Welsh,
  • Moin A Saleem

摘要

Background

Amongst genetic causes of nephrotic syndrome (NS), mutations in the PLCΕ1 gene have been described in patients with early onset NS and diffuse mesangial sclerosis (DMS). However, little is known about how these mutations alter podocyte biology although a role in podocyte differentiation has been proposed (Yu S, et al. Exp Mol Med. 52(4):594–603,2020).

Methods

To explore the role of PLCε in podocytes, A conditionally immortalised human podocyte cell line was generated from a patient with early onset NS, due to a nonsense PLCΕ1 mutation, resulting histologically in diffuse mesangial sclerosis (DMS).

Results

In comparison to wild type podocytes, the PLCΕ1 mutant podocyte cell has reduced epithelial features, altered actin cytoskeleton and significantly lower levels of the epithelial marker ZO-1.

Conclusions

We demonstrate that PLCε deficiency is associated with functionally impaired TGF-β1 responses with an altered SMAD2/SMAD3 ratio and absent SMAD2 phosphorylation, resulting in loss of the motility response to TGF-β1. We further show that PLCE1 knockdown in wild-type podocytes recapitulates this phenotype by knock-down of PLCΕ1 in wild-type podocytes.

This work reveals that disease-causing mutations in PLCΕ1 result in podocyte dedifferentiation and uncovers a novel association between PLCΕ1 deficiency and SMAD2/3 signalling signalling in maintaining podocyte differentiation.